The Aiforia® Lymph Node Metastasis AI model supports the detection and quantification of metastases of breast cancer, melanoma, and colorectal cancer in lymph nodes from whole slide images. Aiforia Technologies Plc, Press Release, September...

Upcoming Aiforia webinar Evaluation of HER2-low and ultralow status of advanced breast carcinomas Monday, September 29, 2025 3-4pm CEST | 9-10 am EDT REGISTER NOW Join this webinar to discover how digital pathology with AI evaluation...

Aiforia announces webinar. Webinar topic: Can AI predict patient outcomes in ovarian cancer? Date: Tuesday, September 16, 2025 Time: 2-3 pm CEST | 8-9 am EDT Register to join live or to get the recording after the...

Milan, 01 September 2025 – Dedalus Group (“Dedalus”), the European leader in healthcare and diagnostic software solutions, and Aiforia Technologies (“Aiforia”), a pioneer in AI-powered image analysis for pathology, today announced a...

Change in Aiforia Technologies Plc’s Management Team Aiforia Technologies Plc, Company release, August 14, 2025 at 9:30 a.m. EEST Thomas Rosqvist (MSc Software Engineering, eMBA) has been appointed as the Chief Technology Officer of...

Aiforia Technologies Plc has established a subsidiary in France to strengthen its local presence and to support its growing business in the country. July 9, 2025, 9:00 a.m. EEST Aiforia Technologies Plc has established a subsidiary in France...